Skip to main content
. 2020 Feb 12;33(4):356–372. doi: 10.1111/tri.13581

Figure 4.

Figure 4

Forest plot of studies comparing risk of biopsy‐proven acute rejection between generic and innovator tacrolimus – stratified by use.